Search the Newsreel

New Forecasts: Here's What Analysts Think The Future Holds For OmniAb, Inc. (NASDAQ:OABI)

Analysts have significantly upgraded their statutory estimates for OmniAb, Inc. (OABI), increasing revenue forecasts and reducing expected losses for 2026. Despite the positive adjustments, the company is still projected to experience a revenue decline faster than the broader industry, although the reduced loss estimates …

AMN Signals Greater Appetite for Acquisitions

AMN Healthcare Services Inc. plans to increase its acquisition activity as both the staffing market and the company's financial health improve. The company recently spent $3 million on two acquisitions, Jaide Health and Essential Leadership Assessment, and executives believe they are now in a …

Amneal (AMRX): Tushar Patel discloses 61.3M-share, 17.6% ownership in 13D/A

Tushar Patel has filed an Amendment No. 6 to his Schedule 13D, disclosing beneficial ownership of 61,341,678 shares of Amneal Pharmaceuticals Class A common stock, representing 17.6% of the outstanding shares. This updated ownership stake reflects shares acquired through the recent Kashiv BioSciences acquisition, …

Amneal Pharmaceuticals (AMRX) ownership shifts with $375M Kashiv deal and new shares

Amneal Pharmaceuticals, Inc. has completed its acquisition of Kashiv BioSciences, LLC for $375 million in cash and 28,942,098 shares of Class A Common Stock. This transaction has resulted in Chintu Patel becoming the beneficial owner of 32,576,528 shares, representing 9.4% of Amneal's Class A …

Amneal Pharmaceuticals (AMRX) director reports 283,632-share grant tied to Kashiv deal

Amneal Pharmaceuticals director Gautam Patel reported an indirect acquisition of 283,632 Class A common shares on August 10, 2026. These shares were received by limited liability companies he manages as part of Amneal's acquisition of Kashiv BioSciences, LLC. Following this transaction, Patel directly holds …

Amneal Pharmaceuticals (AMRX) Co-CEO linked entities receive 6.38M shares in Kashiv deal

Amneal Pharmaceuticals' Co-CEO, Chirag K. Patel, through entities he manages, acquired 6,381,734 Class A common shares on August 10, 2026. This share issuance was part of Amneal's acquisition of Kashiv BioSciences, LLC. After the transaction, Patel holds 1,393,470 shares directly and 21,269,420 shares indirectly …

Omnicom Group Inc Investor Day Transcript

This page provides a transcript of Omnicom Group Inc.'s Investor Day held on March 12, 2026. The event featured presentations by company executives, including Greg Lundberg, Head of Investor Relations. The content lists various past earnings calls and conference transcripts for Omnicom Group Inc. …

Global Indemnity (GBLI) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wed., Aug. 5, 2026 at 11 a.m. ET CALL PARTICIPANTS Chief Operating Officer - Evan KasowitzChief Executive - Jay BrownChief Financial Officer - Brian Riley TAKEAWAYS Net Income -- $11.1 million ($0.76 per share), compared to $10.3 million …

Can Amneal's Kashiv Deal Turn Biosimilars Into a Major Growth Engine?

Amneal Pharmaceuticals AMRX completed its acquisition of Kashiv BioSciences on Monday, creating an integrated global biosimilars platform spanning research, development, manufacturing and commercialization. The deal broadens Amneal's biosimilar capabilities as it seeks more consistent launches. The investment case still depends on integration, regulatory execution …

Is AMRX Stock a Buy as Growth Improves but Execution Risks Persist?

Amneal Pharmaceuticals AMRX enters the second half of 2026 with higher guidance and a broader product pipeline. The company is expanding complex generics, biosimilars and specialty medicines while adjusted earnings and EBITDA improve. The trade-off is clear. Rytary has lost exclusivity, generic pricing remains …

AMRX Stock Surges 44.8% in 3 Months: Can the Rally Keep Running Now?

Amneal Pharmaceuticals AMRX shares have gained 44.8% over the past 12 weeks, putting the durability of the advance in focus. The rally has coincided with better operating results and a higher 2026 outlook. The next leg will depend on whether earnings growth, new launches …

Vuzix Receives Follow-On Smart Glasses Order from Augmex to Support Its U.S. Market Launch

Vuzix Corporation (NASDAQ: VUZI) has received a follow-on smart glasses order from Augmex, a smart glasses solutions provider. This order, which includes Vuzix M400 and LX1 smart glasses, will support Augmex's launch of its solutions in the United States and continued enterprise deployments across …

AMN Healthcare: AI Could Give Nurses Back 240–400 Hours a Year

AMN Healthcare released a white paper projecting persistent healthcare workforce strain through 2030, citing an aging population, rising chronic diseases, and rural access gaps. The report forecasts a physician shortage of up to 86,000 by 2036 and notes that AI-enabled automation could save nurses …

OMCL Falls 20.1% in a Month as Booking and Margin Risks Build

Omnicell (OMCL) shares have

AMN Healthcare Report Projects Persistent Workforce Strain Across Nursing, Allied Health, Physicians and Advanced Practitioners Through 2030

A new white paper by AMN Healthcare projects persistent workforce strain in nursing, allied health, physicians, and advanced practitioners through 2030. The report highlights that an aging population, rising chronic disease prevalence, and rural access gaps will continue to exacerbate staffing shortages. It also …

Quantinno Capital Management LP Has $1.92 Million Position in Omnicell, Inc. $OMCL

Quantinno Capital Management LP significantly increased its stake in Omnicell, Inc. (NASDAQ:OMCL) by 390.2%, now holding 57,560 shares valued at $1.92 million. This move comes as institutional investors collectively own 97.7% of the company, and analysts maintain a "Moderate Buy" rating despite recent price …

NewEdge Advisors LLC Raises Stock Holdings in Omnicom Group Inc. $OMC

NewEdge Advisors LLC significantly increased its stake in Omnicom Group Inc. by 27.8% in the first quarter, now holding 57,040 shares valued at $4.3 million. Despite a slight miss on EPS, Omnicom reported strong quarterly revenue growth and declared a quarterly dividend of $0.80 …

Assenagon Asset Management S.A. Takes Position in Omnicom Group Inc. $OMC

Assenagon Asset Management S.A. has acquired a new stake in Omnicom Group Inc. (NYSE:OMC), purchasing 129,043 shares valued at approximately $9.4 million during the second quarter. Omnicom Group reported strong quarterly revenue growth of 63.4% year-over-year, reaching $6.56 billion, although its EPS of $2.65 …

Global Indemnity Group LLC (GBLI) Earnings Forecast: Future EPS & Revenue Growth Estimates

(OMCL) Price Dynamics and Execution-Aware Positioning

Omnicell Inc. (NASDAQ: OMCL) is exhibiting choppy conditions due to divergent sentiment across all time horizons, with support currently being tested. The AI models have generated three distinct trading strategies: a Position Trading Strategy, a Momentum Breakout Strategy, and a Risk Hedging Strategy, each …

Vuzix smart glasses order is expected to support warehouse and field workflows

Vuzix has received a follow-on order from smart glasses solutions provider Augmex for its M400 and LX1 smart glasses. This order continues a series of purchases and is expected to support Augmex's U.S. market launch, alongside ongoing deployments in Europe for enterprise customers in …

AMN Healthcare Services (AMN) Is Up 7.0% After Q2 Return To Profitability And Stronger Staffing Demand – Has The Bull Case Changed?

AMN Healthcare Services reported a return to profitability in Q2 2026 with US$21.16 million in net income and strong revenue of US$673.24 million, driven by increased demand in travel nursing and allied health staffing. The company's Q3 revenue guidance of US$640–US$655 million reinforces this …

Vuzix receives smart glasses order from Augmex for U.S. launch By Investing.com

Vuzix Corporation (NASDAQ:VUZI) has received an order for its M400 and LX1 smart glasses from Augmex, a solutions provider for enterprise customers. This order supports Augmex's launch in the United States and expansion across various enterprise verticals. Augmex integrates Vuzix smart glasses with its …

Omnicom Group Inc. stock outperforms competitors on strong trading day

Omnicom Group Inc. (OMC) shares rose 1.54% to $85.95 on Tuesday, outperforming the broader market as the S&P 500 and Dow Jones Industrial Average both experienced declines. The company's stock closed 1.67% below its 52-week high.

Is SGI Stock Worth Buying Amid Growth Gains and Execution Risks?

Somnigroup International (SGI) faces a mixed operating environment with growth opportunities from acquisitions and cash generation, but also challenges from weak bedding demand, margin pressures, and execution risks. While the company benefits from its vertically integrated platform and synergies from the Mattress Firm acquisition, …

AMN Healthcare Services (NYSE:AMN) Stock Price Down 6.6% - Here's Why

AMN Healthcare Services (NYSE:AMN) saw its stock price drop 6.6% in light trading, closing at $34.1950, despite strong recent quarterly results where it beat EPS and revenue expectations. Analyst sentiment is mixed, with an overall "Hold" rating and a consensus price target of $30.86. …

Do Wall Street Analysts Like Erie Indemnity Stock?

VUZI Looks 58.2% Overvalued on GF Value™

Vuzix Corp (VUZI) has received a new order for its smart glasses from Augmex, continuing a partnership that began in December 2024. Despite this demand, GuruFocus’ GF Value™ indicates the stock is approximately 58.2% overvalued, trading at a high Price-to-Sales ratio of 33.9 while …

Amneal (AMRX) Is a Great Choice for 'Trend' Investors, Here's Why

Most of us have heard the dictum "the trend is your friend." And this is undeniably the key to success when it comes to short-term investing or trading. But it isn't easy to ensure the sustainability of a trend and profit from it. Often, …

What is Zacks Research's Forecast for GBLI Q3 Earnings?

Zacks Research has lowered its Q3 2026 EPS forecast for Global Indemnity Group (GBLI) to $0.73 from $0.77, also projecting Q4 EPS of $0.59, with the full-year consensus at $2.68. This adjustment follows GBLI missing its recent quarterly earnings expectations with an EPS of …

HC Wainwright Forecasts OmniAb's Q3 Earnings (NASDAQ:OABI)

BMO Capital Keeps Their Buy Rating on AMN Healthcare Services (AMN)

'Unc Found the Meme': Omnicom Advertising and Snapchat Guide Brands Through Next-Gen Humour

Omnicom Advertising and Snapchat released a new global study, "How to Laugh (and Win) with the Next Generation," to help brands connect with Gen Z and Gen Alpha through humor. The research, based on insights from over 6,000 social media users aged 13-28, highlights …

MNTN, Inc Class A Faces Heightened Risk from Costly AI Development, Third‑Party Dependencies, and Intensifying Competition

MNTN, Inc Class A (MNTN) is facing significant risks primarily due to the costly and complex development of its proprietary AI technologies, which could suffer from performance issues, defects, or require continuous intervention. Additionally, the company's heavy reliance on third-party computing infrastructure and licensed …

Millennium reports 3.8% Omnicell (OMCL) stake in amended 13G filing

Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander have collectively reported a beneficial ownership of 1,734,375 shares of Omnicell, Inc. (OMCL) common stock, which represents 3.8% of the outstanding class. This disclosure was made in an amended 13G filing, indicating shared …

Price to sales forward of OmniAb, Inc. – NASDAQ:OABIW

This article provides the "Price to sales forward" metric for OmniAb, Inc. (NASDAQ: OABIW), a company listed on the Nasdaq Stock Market. The content appears to be a financial data snippet from a platform like TradingView, showing the period, value, and change for this …